As of September 2026, 193 paid clinical trials are recruiting in Spokane, Washington. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Spokane offers studies at sites including Providence Sacred Heart Medical Center and Children's Hospital for conditions such as Malignant Solid Neoplasm, Acute Myeloid Leukemia, Breast Cancer, Chronic Lymphocytic Leukemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Researchers run research studies in Spokane, WA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Providence Sacred Heart Medical Center and Children's Hospital | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm | 30 |
| Cancer Care Northwest - Spokane South | Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Ovarian Carcinoma | 23 |
| Cancer Care Northwest-North Spokane | Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Ovarian Carcinoma | 23 |
| Cancer Care Northwest-Valley | Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Ovarian Carcinoma | 21 |
| Spokane Eye Clinical Research | Amblyopia, Age-Related Macular Degeneration, Age-related Macular Degeneration (AMD) | 8 |
| Providence Sacred Heart Medical Center | Alport Syndrome, Central Line Associated Blood Stream Infections (CLABSI), Diabetes Mellitus Type 1 | 7 |
| Inland Northwest Research | Parkinson Disease, Parkinson's Disease, Deep Brain Stimulation | 6 |
| Summit Cancer Centers | Adenoid Cystic Carcinoma, Advanced Metastatic Castration Resistant Prostate Cancer, Advanced Solid Tumor | 5 |
| Cancer Care Northwest | Advanced/Metastatic Solid Tumors, Cancer, Colorectal Cancer | 5 |
| Dermatology Specialists of Spokane | Alopecia Areata, Alopecia Areata (AA), Hidradenitis Suppurativa (HS) | 5 |
| Providence Sacred Heart Medical Center & Children's Hospital | Fallopian Tube Cancer, Endometrioid Ovarian Cancer, Epithelial Ovarian Cancer | 5 |
| Spokane Urology | High-Risk Non-Muscle-Invasive Bladder Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Non-Muscle Invasive Bladder Neoplasms | 4 |
| Washington State University College of Pharmacy and Pharmaceutical Sciences | Interaction, Herbal Interaction | 4 |
| Premier Clinical Research | Actinic Keratosis, Plaque Psoriasis | 3 |
| Medical Oncology Associates - Spokane | CLL, CLL (Chronic Lymphocytic Leukemia), CLL / SLL | 3 |
| Arthritis Northwest | Acute Gout Flare, Arthritis, Gout | 2 |
| Principle Research Solutions | Alopecia Areata, Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate | 2 |
| Providence Medical Group, Cystic Fibrosis Clinic | Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation | 2 |
| Providence Medical Research Center | Cystic Fibrosis, Glomerulosclerosis, Focal Segmental, Infections | 2 |
| Sleep and Performance Research Center | Cataplexy, Circadian Misalignment, Circadian Rhythm | 2 |
| Spokane Joint Replacement Center | Osteoarthritis, Symptomatic Venous Thromboembolism (VTE) | 2 |
| Summit Cancer Centers - North Spokane | B-cell Non Hodgkin Lymphoma, Hepatocellular Carcinoma | 2 |
| Velocity Clinical Research - Spokane | Atherosclerotic Cardiovascular Disease, Diabetic Peripheral Neuropathic Pain, Obesity | 2 |
| Velocity Clinical Research-Spokane-69716 | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 2 |
| Vima | Dystonia, PARKINSON DISEASE (Disorder) | 2 |
Recruiting trials in Spokane grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 193 recruiting clinical trials in Spokane, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Spokane compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Spokane include Malignant Solid Neoplasm (5), Acute Myeloid Leukemia (4), Breast Cancer (4), Chronic Lymphocytic Leukemia (4), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Spokane on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Spokane include Providence Sacred Heart Medical Center and Children's Hospital, Cancer Care Northwest - Spokane South, Cancer Care Northwest-North Spokane, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Spokane are Cancer & tumors (75), Neurology & pain (9), Diabetes & metabolic (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.